China Yongxin Pharmaceuticals Opened Three New Stores in 2009 and Expanded Customer Base

CHANGCHUN, China and LOS ANGELES , Jan. 8 /PRNewswire-Asia/ -- China Yongxin Pharmaceuticals, Inc. (OTC Bulletin Board: CYXN; "China Yongxin Pharmaceuticals" or the "Company"), is a leading manufacturer, distributor and retailer of Chinese traditional medicines, pharmaceutical products, natural health products, health food, cosmetics, and medical equipment in Northeastern China . The Company today announced that it had opened three new stores in 2009.

Reflecting a transition in the Company's sales strategy, the Company opened three new retail stores in 2009. Among them, two stores are located in Tianjin City with an average operating area of 100 square meters per store. Covering a local customer population of 23,000, each store offers more than 1,500 products and has achieved an average revenue of $429 per store per day.

With an operating area of 140 square meters, the new store in Changchun City offers more than 3,000 products to a local customer population of 27,000. It has also realized an average revenue of $429 per day.

With the new stores, the Company now has 96 stores in total in China (including 22 franchisees), offering a broader product portfolio including 98% of the items listed on the recently issued Essential Drug List (EDL) in China . With expanded marketing activities, these new stores contributed to increased revenues in 2009 from the Company's retail drug operations, which increased by approximately 30% over the prior year. These new stores also helped to improve the Company's 2009 gross profit which was $15.2 million and gross margin of 32.6%, representing a significant improvement over the $11.9 million in gross profit and gross margin of 20.1% for 2008.

Mr. Yongxin Liu , Chairman and Chief Executive Officer of China Yongxin, commented, "With enhanced government support, specifically the commencement of China's $126 billion health care reform plan focused on providing a broader spectrum of healthcare services and pharmaceutical products to all Chinese residents, we are confident that our modernized logistics center and distribution channels, the broad customer base of our chain drugstores, our extensive product portfolio, and committed management team will enable us to resume our growth momentum and capitalize on a long- term, secular growth opportunity."

About China Yongxin Pharmaceuticals, Inc.

China Yongxin Pharmaceuticals, Inc. was founded in 1993 as the Changchun Yongxin Dirui Medical Co., Ltd. (Yongxin), is a manufacturer, retailer and distributor of Chinese traditional medicines, pharmaceutical preparations, natural health products, health food, cosmetics, and medical equipment in Northeastern China . Its retail operations began in 2004, and in 2005, it gained franchise rights from one of the world's largest drug chains for China's Jilin Province . By the end of 2007, the Company had become one of the fastest growing drug retailers in China through its retail chain of 93 drug outlets as well as wholesale distribution and manufacturing operations in Northeastern China . For more information about China Yongxin Pharmaceuticals, please visit http://www.yongxinchina.com .

Forward Looking Statements

This news release contains certain "forward-looking statements." Forward- looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. The forward-looking statements are also identified through the use of words "believe," enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict" "probable," "potential," "possible," "should," "continue," "project", "expect" and other words of similar meaning. Actual results could differ materially from these forward-looking statements as a result of a number of risk factors detailed in the Company's periodic reports filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. China Yongxin Pharmaceutical Inc. does not assume any duty to publicly update or revise the material contained herein.

    For more information, please contact:

    For the Company:
     Mr. Sam Liu, COO
     China Yongxin Pharmaceuticals, Inc.
     Tel:   +1-626-581-9098
     Email: [email protected]

    Investors:
     Mr. Matthew Hayden, HC International
     Tel:   +1-561-245-5155
     Email: [email protected]
     Web:   http://www.hcinternational.net

SOURCE China Yongxin Pharmaceuticals, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED